GREM1 Antikörper (C-Term) (Biotin)
Kurzübersicht für GREM1 Antikörper (C-Term) (Biotin) (ABIN2277096)
Target
Alle GREM1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 111-139, C-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- GREM1, CT (GREM1, CKTSF1B1, DAND2, DRM, Gremlin-1, Cell proliferation-inducing gene 2 protein, Cysteine knot superfamily 1, BMP antagonist 1, DAN domain family member 2, Down-regulated in Mos-transformed cells protein, Increased in high glucose protein 2) (Biotin)
-
Aufreinigung
- Purified by Protein A affinity chromatography
-
Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 111-139 in the C-terminal region of human GREM1, UniProt Accession #O60565. Species Sequence Homology: mouse and rat
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- GREM1 (Gremlin 1 (GREM1))
-
Andere Bezeichnung
- GREM1
-
NCBI Accession
- NP_037504
-
UniProt
- O60565
-
Pathways
- Regulation of Muscle Cell Differentiation, Tube Formation, Maintenance of Protein Location
Target
-